Clara Escudero-Duch

Years Active: 2020-2023
Publications (10 Years): 5

Hospital La Paz Institute for Health Research

Universidad Complutense de Madrid (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital La Paz Institute for Health Research Jun 03 2019

Spain

Postdoctoral Researcher :: Fisiopatologia ósea y biomateriales

Hospital La Paz Institute for Health Research Jan 01 2015 - Dec 31 2018

Spain

PhD student :: Fisiopatologia ósea y biomateriales

Universidad Complutense de Madrid Sep 15 2012 - Jul 15 2014

Spain

Colaboradora honorifica :: Microbiologia III

Universidad Complutense de Madrid Sep 15 2011 - Jun 20 2012

Spain

Becaria de colaboración :: microbiologia III

Education History

Universidad Complutense de Madrid Sep 15 2012 - Jul 15 2013

Spain

MSC :: Facultad de químicas

Publications

Nuria Vilaboa, Juan Antonio López, Marco de Mesa, Clara Escudero-Duch, Natalie Winfield, Melanie Bayford, Richard Voellmy
Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Nuria Vilaboa, Juan Antonio López, Marco de Mesa, Clara Escudero-Duch, Natalie Winfield, Melanie Bayford, Richard Voellmy
Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Nuria Vilaboa, Juan Antonio López, Marco de Mesa, Clara Escudero-Duch, Natalie Winfield, Melanie Bayford, Richard Voellmy
Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Nuria Vilaboa, Juan Antonio López, Marco de Mesa, Clara Escudero-Duch, Natalie Winfield, Melanie Bayford, Richard Voellmy
Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Clara Escudero-Duch, Nuria Vilaboa
Recent efforts in the development of nanomaterials to control transgene expression. Nanomedicine (London, England) 15 (21) (2020)

Clara Escudero-Duch.css-eqlu8i{font-size:small;padding-left:4px;}